A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2017; you can also visit the original URL.
The file type is application/pdf.
Neuroendocrine Carcinoma of the Gallbladder
2014
Journal of Gastroenterology Pancreatology & Liver Disorders
Preserved Fulltext
Open Access Letter to Editor was diagnosed. He received adjuvant chemotherapy with 5-flurouracil and cisplatin for 2 months but could not tolerate. He died of metastatic disease and complications after 6 months. Gallbladder carcinoma is the fifth most common gastrointestinal malignancy more than which 90% is Adenocarcinoma (AC). Neuroendocrine Tumors (NETs) make up of 4% of all gallbladder cancers and NECs make up even a smaller percentage [1]. The age of presentation ranges from 38 to 81 years
doi:10.15226/2374-815x/1/3/00117
fatcat:6bhugnc5trbwzbq7y3jmfsr5oa